curve stripping techniques rstrip v.4.03 (MicroMath Inc)
90
Structured Review
MicroMath Inc
curve stripping techniques rstrip v.4.03
Curve Stripping Techniques Rstrip V.4.03, supplied by MicroMath Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/curve+stripping+techniques+rstrip+v%2E4%2E03/curve+stripping+techniques+rstrip+v+4+03/pm09788577-100-20-22
Average 90 stars, based on 1 article reviews
Curve Stripping Techniques Rstrip V.4.03, supplied by MicroMath Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/curve+stripping+techniques+rstrip+v%2E4%2E03/curve+stripping+techniques+rstrip+v+4+03/pm09788577-100-20-22
Average 90 stars, based on 1 article reviews
curve stripping techniques rstrip v.4.03 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Selection:Article Title: Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer. Article Snippet: Purpose: Both ondansetron and cyclophosphamide are thought to be metabolized by hepatic microsomal processes.. The purpose of this study was to evaluate the potential pharmacokinetic interactions between ondansetron and high-dose alkylating agent chemotherapy.. Methods: A total of 54 breast cancer patients receiving high-dose cyclophosphamide, cisplatin and carmustine were treated prospectively in four sequential cohorts. Stripping Membranes:Article Title: Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer. Article Snippet: Purpose: Both ondansetron and cyclophosphamide are thought to be metabolized by hepatic microsomal processes.. The purpose of this study was to evaluate the potential pharmacokinetic interactions between ondansetron and high-dose alkylating agent chemotherapy.. Methods: A total of 54 breast cancer patients receiving high-dose cyclophosphamide, cisplatin and carmustine were treated prospectively in four sequential cohorts. |